NFSG
PRAX icon

Newbridge Financial Services Group’s Praxis Precision Medicines PRAX Stock Holding History

Newbridge Financial Services Group’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2
Closed -$39 – 1293
2023
Q3 		$39 Hold
2
– – ﹤0.01% 1264
2023
Q2 		$26 Hold
2
– – ﹤0.01% 1333
2023
Q1 		$19 Hold
2
– – ﹤0.01% 1395
2022
Q4 		$55 Hold
2
– – ﹤0.01% 1412
2022
Q3 		$0 Hold
2
– – ﹤0.01% 1458
2022
Q2 		$0 Hold
2
– – ﹤0.01% 1486
2022
Q1 		$0 Hold
2
– – ﹤0.01% 1530
2021
Q4 		$0 Hold
2
– – ﹤0.01% 1511
2021
Q3 		$1K Hold
2
– – ﹤0.01% 1296
2021
Q2 		$0 Hold
2
– – ﹤0.01% 1499
2021
Q1 		$1K Buy
+2
New +$1.42K ﹤0.01% 1310

Other funds holding PRAX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Newbridge Financial Services Group's PRAX Position: Q4 2023 in Review

Newbridge Financial Services Group sold out of Praxis Precision Medicines (PRAX) in Q4 2023, closing a stake of 2 shares — an estimated $39 sold.

Newbridge Financial Services Group first reported a position in PRAX in Q1 2021 and held it in 11 quarters. The position peaked at $1K in Q3 2021. 60 funds tracked by Wall St. Rank hold PRAX as of Q4 2023.

  • Newbridge Financial Services Group reported no remaining Praxis Precision Medicines position as of Q4 2023 after selling out during the quarter.
  • Newbridge Financial Services Group sold 2 Praxis Precision Medicines shares in Q4 2023, an estimated $39.
  • Newbridge Financial Services Group first reported a position in Praxis Precision Medicines in Q1 2021 and held it in 11 quarters.
  • Newbridge Financial Services Group's Praxis Precision Medicines position peaked at $1K in Q3 2021.
  • 60 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q4 2023.

Based on Newbridge Financial Services Group's 13F filing for Q4 2023, filed 28 Mar 2024.